A Peek Into Livelihood Scheme for Migrant Workers | Finance minister Nirmala Sitharaman gave glimpse of the Garib Kalyan Rojgar Abhiyaan scheme which is aimed at providing livelihood opportunities to migrant workers who returned to their home states during the coronavirus lockdown. Read full article here
Jharkhand today banned consumption of all types of tobacco products at public places in the entire state in view of the rising number of coronavirus cases. Meanwhile, the World Health Organization has decided to halt trials of hydroxychloroquine as a potential treatment for hospitalised Covid-19 patients, finding it did not reduce the mortality rate. A decades-old malaria and rheumatoid arthritis drug, hydroxychloroquine has been at the centre of political and scientific controversy. It has been touted as a possible treatment for the new coronavirus by high profile figures, including US President Donald Trump.
A Peek Into Livelihood Scheme for Migrant Workers | Finance minister Nirmala Sitharaman gave glimpse of the Garib Kalyan Rojgar Abhiyaan scheme which is aimed at providing livelihood opportunities to migrant workers who returned to their home states during the coronavirus lockdown. Read full article here
Delhi to Receive 6L Antigen Test Kits | Delhi to be 6,00,000 antigen test kits by a South Korean company for testing in containment zones and hospitals. Yesterday, 50,000 kits were given, and another 50,000 will be given out tomorrow. Within next 4-5 days, the entire lot will be delivered in phases to the Delhi government.
Andhra Pradesh Covid-19 Count | The COVID-19 surge continued unabated in Andhra Pradesh with a record single day high of 425 new cases being added, taking the overall tally to 7,496. The coronavirus toll also continued its upward trend as two more patients died in Krishna district, making it a total of 92 so far in the state, according to the latest bulletin.
Kejriwal inspects covid-19 care centre at the Radha Soami Satsang Beas in Chhatarpur.
Inspected Delhi govt's upcoming 10,000 bed Covid Care Centre at the Radha Soami Satsang Beas grounds at Chhatarpur. A small section of the beds will also have oxygen support. #DelhiFightsCorona pic.twitter.com/htSW9uEQSi
— Arvind Kejriwal (@ArvindKejriwal) June 18, 2020
IIT Madras' Measures against Covid-19 | IIT Madras Director Prof Bhaskar Ramamurthi spoke to News18.com on the institute retaining it's number one spot in MHRD's list of top engineering institutes in India on one hand and slipping in the QS World University Rankings 2021 on the other. He discusses how the premier institute used smart bins, 3D-printed PPEs and wearable trackers in its fight against Covid-19. Read his interview with Eram Agha here

EU in Advanced Talks with Johnson & Johnson on Vaccine Deal | The European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development, two officials familiar with the talks told Reuters. The Commission's deal with the US firm is "in the pipeline", a top health official from an EU member state said, asking to remain anonymous as was mentioning confidential discussions about vaccines between the EU executive and EU governments.
EU in Advanced Talks with Johnson & Johnson on Vaccine Deal | The European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development, two officials familiar with the talks told Reuters. The Commission's deal with the US firm is "in the pipeline", a top health official from an EU member state said, asking to remain anonymous as was mentioning confidential discussions about vaccines between the EU executive and EU governments.
EU in Advanced Talks with Johnson & Johnson on Vaccine Deal | The European Commission is in advanced talks with pharmaceutical giant Johnson & Johnson to reserve or buy up-front doses of its COVID-19 vaccine under development, two officials familiar with the talks told Reuters. The Commission's deal with the US firm is "in the pipeline", a top health official from an EU member state said, asking to remain anonymous as was mentioning confidential discussions about vaccines between the EU executive and EU governments.
Amma Canteens to Resume Free Food during 12-day Lockdown | The ruling AIADMK's flagship Amma Canteens will provide free food for 12 days from Friday onwards in Chennai and three neighbouring districts where the lockdown curbs are being tightened to prevent the spread of COVID-19, Chief Minister K Palaniswami said. Food will also be provided through community kitchens and home delivered to select sections of the population such as the aged, he said in a statement.
Maha CM Calls for Low-key Ganpati Festival | Maharashtra Chief Minister Uddhav Thackeray called for a simple and low-key Ganpati festival celebration this year in view of the COVID-19 pandemic, and asked Ganesh mandals to undertake social welfare programmes. Thackeray said the threat of coronavirus is not yet over and therefore, it will not be possible to celebrate the Ganesh festival with the usual pomp and gaiety. He said there should be no crowding or processions during the festival.
Covid-19 Testing in Delhi | Two important developments in Covid-19 testing in Delhi:
1. The price of testing for Covid-19 has been reduced to Rs 2,400.
2. Starting today, Delhi has started rapid antigen tests, the results of which become available within 15 minutes.
I hope the people of Delhi will not face any problems in testing now.
दिल्ली में करोना की टेस्टिंग -आज दो महत्वपूर्ण घटनायें हुईं
— Arvind Kejriwal (@ArvindKejriwal) June 18, 2020
1. दिल्ली में टेस्टिंग के रेट घटाकर 2400 रुपए किए
2. आज से दिल्ली में रैपिड ऐंटिजेन टेस्टिंग शुरू हुई जिसके नतीजे 15 मिनट में आ जाते हैं
उम्मीद करता हूँ कि अब दिल्ली के लोगों को टेस्टिंग की कोई समस्या नहीं होगी
The World Health Organization is looking at interim data from its large multi-country trial of the combination of HIV drugs Lopinavir and Ritonavir to treat Covid-19 patients, the UN agency’s chief scientist Soumya Swaminathan said.
The Solidarity Trial's hydroxychloroquine arm is being stopped, on the basis of evidence showing it does not reduce mortality for hospitalised #COVID19 patients.
— World Health Organization (WHO) (@WHO) June 17, 2020
28-Year-Old Excise Personnel Dies of COVID-19 in Kerala | A 28-year old Excise department personnel in Kerala died of COVID-19, taking the toll due to the disease to 21, officials said. Sunil K P attached to Mattannur Excise office in Kannur district died at the Medical College Hospital here, two days after he tested positive for the virus, a senior health official said.
READ | India Slowest among 8 Nations to Record 10k Deaths, but Sees Significant Spike in Mortality Rate Post Unlock 1.0

India reported its first death on March 12 which means that it took 96 days to cross 10,000 deaths – the slowest (in terms of the number of days) amongst the eight countries.
Greek Community in Lockdown After Spike in Cases | Greek civil protection authorities have imposed a seven-day complete lockdown on a community in northeastern Greece, after a spike in coronavirus cases there over the past week. Residents of the Echinos community in the province of Xanthi are forbidden from leaving the area.
Singapore Reports 257 New Cases Among Foreigners | Singapore confirmed 257 new COVID-19 infections among foreign workers, taking the total number of coronavirus cases in the country to 41,473. The new patients include four community cases, including one permanent resident (foreigner), the health ministry said.
Indonesia Reports Record High Cases | Indonesia has reported 1,331 new coronavirus infections, its biggest daily increase since the outbreak started locally, taking its total number of cases to 42,762. Achmad Yurianto, a health ministry official, said 63 more deaths were reported, with total fatalities now at 2,339, the highest coronavirus death toll in East Asia outside of China.
Bangladeshi Group Sends Cards, Baskets to Covid-19 Patients | Volunteers working for a foundation, known for its food assistance programmes for street children and the poor are now sending baskets and cards to Covid-19 patients. This is to build awareness of COVID-19 among families of virus' victims and the community. Its efforts have been inspired by news reports of neglect of victims, or hostility toward them.
HC Asks Health Ministry to Consider Publishing Certain Changes in Pics on Wearing Mask | The Delhi High Court has asked the health ministry to consider publicising in print and electronic media with certain changes in the pictorial presentation of how and when to wear face mask' during the COVID-19 pandemic.
READ | 'Lord Jagannath Won’t Forgive Us if We Allow Procession': SC Stops Puri Rath Yatra Over Covid-19 Concerns

The bench also turned down a request by Solicitor General Tushar Mehta to grant some relaxation for the temple management to conduct certain rituals after observing the norms.

Union Home Minister Amit Shah holds a meeting with Lieutenant Governor Anil Baijal, Chief Minister Arvind Kejriwal and others to discuss the situation in Delhi.
The drug has been included in several randomised clinical trials -- considered the gold standard for clinical investigation -- but the WHO said the evidence had led the UN health agency to call time on its own trials. Doctor Ana Maria Henao Restrepo, from the WHO's health emergencies programme, told a virtual press conference in Geneva that it was being withdrawn from its multi-country Solidarity Trial of a range of potential treatments. "The internal evidence from the Solidarity/Discovery Trial, the external evidence from the Recovery Trial and the combined evidence from these large randomised trials, brought together, suggest that hydroxychloroquine -- when compared with the standard of care in the treatment of hospitalised COVID-19 patients -- does not result in the reduction of the mortality of those patients," she said.
"Based on this analysis and on the review of the published evidence, the Executive Group of the Solidarity/Recovery Trial has met on two occasions and today we met with all the principal investigators. After deliberation, they have concluded that the hydroxychloroquine arm will be stopped from the Solidarity Trial."
British trial results
Henao Restrepo said it was not a WHO policy recommendation and the decision to stop testing it on COVID-19 hospital patients did not apply to the use or the evaluation of the drug as a potential preventative measure against the virus.
Earlier this month, the Recovery Trial -- a major trial run by the University of Oxford -- found hydroxychloroquine had "no benefit" for patients hospitalised with COVID-19.
The British trial, the biggest so far to come forward with findings, said it would stop recruiting patients to be given hydroxychloroquine "with immediate effect".
"Our conclusion is that this treatment does not reduce the risk of dying from COVID among hospital patients," said Martin Landray, an Oxford professor of medicine and epidemiology who co-leads the study.
The randomised clinical trial has recruited a total of 11,000 patients from 175 hospitals in the UK to test a range of potential treatments.
The WHO announcement came after the United States on Monday withdrew emergency use authorisations for hydroxychloroquine and chloroquine -- both favoured by Trump to treat the new coronavirus.
Solidarity Trial
The WHO's Solidarity Trial is testing a series of drugs in a bid to pinpoint which are the most effective against the new coronavirus, in coordinated, randomised trials spanning several countries.
It aims to discover rapidly whether any of the drugs being tested slow disease progression or improve survival. Other drugs could be added in, based on emerging evidence.
As of June 3, more than 3,500 patients have been recruited in 35 countries, with more than 400 hospitals actively recruiting patients.
On May 25, the WHO announced it had temporarily suspended trials of hydroxychloroquine to conduct a safety review. The decision to pause came after a study published in The Lancet medical journal suggesting the drug could increase the risk of death among COVID-19 patients.
The Lancet corrected part of the data, but the study's researchers stood by their conclusions. By early June, the WHO concluded there was "no reason" to change the way its trials were being conducted and resumed hydroxychloroquine testing.
Live TV
Recommended For You
Chinese Apps Flagged by Indian Intel Agencies: TikTok, Xiaomi Apps and 50 Others on List
After Mukesh Chhabra, Rhea Chakraborty Records Statement in Sushant Singh Rajput Suicide Case
How Sushant Singh Rajput Became A Beacon Of Hope For All Outsiders And TV Actors
Cristiano Ronaldo Does Not Get to Take Penalty as Napoli Beat Juventus in Shootout to Win Coppa Italia
Indians Are Using 'Winnie the Pooh' to Taunt Xi Jinping Amid India-China Border Violence